Sr. No. |
Cat No. |
Product Description |
Pack Size |
2001 |
ICH5101-20mg |
Teplizumab Biosimilar – Research Grade |
20mg |
2002 |
ICH5101-50mg |
Teplizumab Biosimilar – Research Grade |
50mg |
2003 |
ICH5101-5mg |
Teplizumab Biosimilar – Research Grade |
5mg |
2004 |
ICH5102-100mg |
Tanezumab Biosimilar – Research Grade |
100mg |
2005 |
ICH5102-10mg |
Tanezumab Biosimilar – Research Grade |
10mg |
2006 |
ICH5102-1mg |
Tanezumab Biosimilar – Research Grade |
1mg |
2007 |
ICH5102-20mg |
Tanezumab Biosimilar – Research Grade |
20mg |
2008 |
ICH5102-50mg |
Tanezumab Biosimilar – Research Grade |
50mg |
2009 |
ICH5102-5mg |
Tanezumab Biosimilar – Research Grade |
5mg |
2010 |
ICH5103-100mg |
Tabalumab Biosimilar – Research Grade |
100mg |
2011 |
ICH5103-10mg |
Tabalumab Biosimilar – Research Grade |
10mg |
2012 |
ICH5103-1mg |
Tabalumab Biosimilar – Research Grade |
1mg |
2013 |
ICH5103-20mg |
Tabalumab Biosimilar – Research Grade |
20mg |
2014 |
ICH5103-50mg |
Tabalumab Biosimilar – Research Grade |
50mg |
2015 |
ICH5103-5mg |
Tabalumab Biosimilar – Research Grade |
5mg |
2016 |
ICH5103B-0.1mg |
Tabalumab Biosimilar – Biotin Research Grade |
100ug |
2017 |
ICH5103D488-0.1mg |
Tabalumab Biosimilar – Dylight488 Research Grade |
100ug |
2018 |
ICH5103HRP-0.1mg |
Tabalumab Biosimilar – HRP Research Grade |
100ug |
2019 |
ICH5103PE-50ug |
Tabalumab Biosimilar – PE Research Grade |
50ug |
2020 |
ICH5104-100mg |
Siltuximab Biosimilar – Research Grade |
100mg |
2021 |
ICH5104-10mg |
Siltuximab Biosimilar – Research Grade |
10mg |
2022 |
ICH5104-1mg |
Siltuximab Biosimilar – Research Grade |
1mg |
2023 |
ICH5104-20mg |
Siltuximab Biosimilar – Research Grade |
20mg |
2024 |
ICH5104-50mg |
Siltuximab Biosimilar – Research Grade |
50mg |
2025 |
ICH5104-5mg |
Siltuximab Biosimilar – Research Grade |
5mg |
2026 |
ICH5105-100mg |
Sifalimumab Biosimilar – Research Grade |
100mg |
2027 |
ICH5105-10mg |
Sifalimumab Biosimilar – Research Grade |
10mg |
2028 |
ICH5105-1mg |
Sifalimumab Biosimilar – Research Grade |
1mg |
2029 |
ICH5105-20mg |
Sifalimumab Biosimilar – Research Grade |
20mg |
2030 |
ICH5105-50mg |
Sifalimumab Biosimilar – Research Grade |
50mg |
2031 |
ICH5105-5mg |
Sifalimumab Biosimilar – Research Grade |
5mg |
2032 |
ICH5106-100mg |
Satralizumab Biosimilar – Research Grade |
100mg |
2033 |
ICH5106-10mg |
Satralizumab Biosimilar – Research Grade |
10mg |
2034 |
ICH5106-1mg |
Satralizumab Biosimilar – Research Grade |
1mg |
2035 |
ICH5106-20mg |
Satralizumab Biosimilar – Research Grade |
20mg |
2036 |
ICH5106-50mg |
Satralizumab Biosimilar – Research Grade |
50mg |
2037 |
ICH5106-5mg |
Satralizumab Biosimilar – Research Grade |
5mg |
2038 |
ICH5107-100mg |
Sarilumab Biosimilar – Research Grade |
100mg |
2039 |
ICH5107-10mg |
Sarilumab Biosimilar – Research Grade |
10mg |
2040 |
ICH5107-1mg |
Sarilumab Biosimilar – Research Grade |
1mg |
2041 |
ICH5107-20mg |
Sarilumab Biosimilar – Research Grade |
20mg |
2042 |
ICH5107-50mg |
Sarilumab Biosimilar – Research Grade |
50mg |
2043 |
ICH5107-5mg |
Sarilumab Biosimilar – Research Grade |
5mg |
2044 |
ICH5107APC-50ug |
Sarilumab Biosimilar – Research Grade: APC |
50ug |
2045 |
ICH5107B-0.1mg |
Sarilumab Biosimilar – Biotin Research Grade |
100ug |
2046 |
ICH5107D488-0.1mg |
Sarilumab Biosimilar – Dylight488 Research Grade |
100ug |
2047 |
ICH5107HRP-0.1mg |
Sarilumab Biosimilar – HRP Research Grade |
100ug |
2048 |
ICH5107PE-50ug |
Sarilumab Biosimilar – Research Grade: PE |
50ug |
2049 |
ICH5108-100mg |
Romosozumab Biosimilar – Research Grade |
100mg |
2050 |
ICH5108-10mg |
Romosozumab Biosimilar – Research Grade |
10mg |
2051 |
ICH5108-1mg |
Romosozumab Biosimilar – Research Grade |
1mg |
2052 |
ICH5108-20mg |
Romosozumab Biosimilar – Research Grade |
20mg |
2053 |
ICH5108-50mg |
Romosozumab Biosimilar – Research Grade |
50mg |
2054 |
ICH5108-5mg |
Romosozumab Biosimilar – Research Grade |
5mg |
2055 |
ICH5109-100mg |
Robatumumab Biosimilar – Research Grade |
100mg |
2056 |
ICH5109-10mg |
Robatumumab Biosimilar – Research Grade |
10mg |
2057 |
ICH5109-1mg |
Robatumumab Biosimilar – Research Grade |
1mg |
2058 |
ICH5109-20mg |
Robatumumab Biosimilar – Research Grade |
20mg |
2059 |
ICH5109-50mg |
Robatumumab Biosimilar – Research Grade |
50mg |
2060 |
ICH5109-5mg |
Robatumumab Biosimilar – Research Grade |
5mg |
2061 |
ICH5110-100mg |
Rilotumumab Biosimilar – Research Grade |
100mg |
2062 |
ICH5110-10mg |
Rilotumumab Biosimilar – Research Grade |
10mg |
2063 |
ICH5110-1mg |
Rilotumumab Biosimilar – Research Grade |
1mg |
2064 |
ICH5110-20mg |
Rilotumumab Biosimilar – Research Grade |
20mg |
2065 |
ICH5110-50mg |
Rilotumumab Biosimilar – Research Grade |
50mg |
2066 |
ICH5110-5mg |
Rilotumumab Biosimilar – Research Grade |
5mg |
2067 |
ICH5111-100mg |
Ponezumab Biosimilar – Research Grade |
100mg |
2068 |
ICH5111-10mg |
Ponezumab Biosimilar – Research Grade |
10mg |
2069 |
ICH5111-1mg |
Ponezumab Biosimilar – Research Grade |
1mg |
2070 |
ICH5111-20mg |
Ponezumab Biosimilar – Research Grade |
20mg |
2071 |
ICH5111-50mg |
Ponezumab Biosimilar – Research Grade |
50mg |
2072 |
ICH5111-5mg |
Ponezumab Biosimilar – Research Grade |
5mg |
2073 |
ICH5112-100mg |
Penpulimab Biosimilar – Research Grade |
100mg |
2074 |
ICH5112-10mg |
Penpulimab Biosimilar – Research Grade |
10mg |
2075 |
ICH5112-1mg |
Penpulimab Biosimilar – Research Grade |
1mg |
2076 |
ICH5112-20mg |
Penpulimab Biosimilar – Research Grade |
20mg |
2077 |
ICH5112-50mg |
Penpulimab Biosimilar – Research Grade |
50mg |
2078 |
ICH5112-5mg |
Penpulimab Biosimilar – Research Grade |
5mg |
2079 |
ICH5113-100mg |
Vudalimab Biosimilar – Research Grade |
100mg |
2080 |
ICH5113-10mg |
Vudalimab Biosimilar – Research Grade |
10mg |
2081 |
ICH5113-1mg |
Vudalimab Biosimilar – Research Grade |
1mg |
2082 |
ICH5113-20mg |
Vudalimab Biosimilar – Research Grade |
20mg |
2083 |
ICH5113-50mg |
Vudalimab Biosimilar – Research Grade |
50mg |
2084 |
ICH5113-5mg |
Vudalimab Biosimilar – Research Grade |
5mg |
2085 |
ICH5114-100mg |
Farletuzumab Biosimilar – Research Grade |
100mg |
2086 |
ICH5114-10mg |
Farletuzumab Biosimilar – Research Grade |
10mg |
2087 |
ICH5114-1mg |
Farletuzumab Biosimilar – Research Grade |
1mg |
2088 |
ICH5114-20mg |
Farletuzumab Biosimilar – Research Grade |
20mg |
2089 |
ICH5114-50mg |
Farletuzumab Biosimilar – Research Grade |
50mg |
2090 |
ICH5114-5mg |
Farletuzumab Biosimilar – Research Grade |
5mg |
2091 |
ICH5115-100mg |
Canakinumab Biosimilar – Research Grade |
100mg |
2092 |
ICH5115-10mg |
Canakinumab Biosimilar – Research Grade |
10mg |
2093 |
ICH5115-1mg |
Canakinumab Biosimilar – Research Grade |
1mg |
2094 |
ICH5115-20mg |
Canakinumab Biosimilar – Research Grade |
20mg |
2095 |
ICH5115-50mg |
Canakinumab Biosimilar – Research Grade |
50mg |
2096 |
ICH5115-5mg |
Canakinumab Biosimilar – Research Grade |
5mg |
2097 |
ICH5116-100mg |
Zalutumumab Biosimilar – Research Grade |
100mg |
2098 |
ICH5116-10mg |
Zalutumumab Biosimilar – Research Grade |
10mg |
2099 |
ICH5116-1mg |
Zalutumumab Biosimilar – Research Grade |
1mg |
2100 |
ICH5116-20mg |
Zalutumumab Biosimilar – Research Grade |
20mg |
2101 |
ICH5116-50mg |
Zalutumumab Biosimilar – Research Grade |
50mg |
2102 |
ICH5116-5mg |
Zalutumumab Biosimilar – Research Grade |
5mg |
2103 |
ICH5117-100mg |
Relatlimab Biosimilar – Research Grade |
100mg |
2104 |
ICH5117-10mg |
Relatlimab Biosimilar – Research Grade |
10mg |
2105 |
ICH5117-1mg |
Relatlimab Biosimilar – Research Grade |
1mg |
2106 |
ICH5117-20mg |
Relatlimab Biosimilar – Research Grade |
20mg |
2107 |
ICH5117-50mg |
Relatlimab Biosimilar – Research Grade |
50mg |
2108 |
ICH5117-5mg |
Relatlimab Biosimilar – Research Grade |
5mg |
2109 |
ICH5118-100mg |
8H9 Biosimilar – Research Grade |
100mg |
2110 |
ICH5118-10mg |
8H9 Biosimilar – Research Grade |
10mg |
2111 |
ICH5118-1mg |
8H9 Biosimilar – Research Grade |
1mg |
2112 |
ICH5118-20mg |
8H9 Biosimilar – Research Grade |
20mg |
2113 |
ICH5118-50mg |
8H9 Biosimilar – Research Grade |
50mg |
2114 |
ICH5118-5mg |
8H9 Biosimilar – Research Grade |
5mg |
2115 |
ICH5119-100mg |
Ivuxolimab Biosimilar – Research Grade |
100mg |
2116 |
ICH5119-10mg |
Ivuxolimab Biosimilar – Research Grade |
10mg |
2117 |
ICH5119-1mg |
Ivuxolimab Biosimilar – Research Grade |
1mg |
2118 |
ICH5119-20mg |
Ivuxolimab Biosimilar – Research Grade |
20mg |
2119 |
ICH5119-50mg |
Ivuxolimab Biosimilar – Research Grade |
50mg |
2120 |
ICH5119-5mg |
Ivuxolimab Biosimilar – Research Grade |
5mg |
2121 |
ICH5120-100mg |
Labetuzumab Biosimilar – Research Grade |
100mg |
2122 |
ICH5120-10mg |
Labetuzumab Biosimilar – Research Grade |
10mg |
2123 |
ICH5120-1mg |
Labetuzumab Biosimilar – Research Grade |
1mg |
2124 |
ICH5120-20mg |
Labetuzumab Biosimilar – Research Grade |
20mg |
2125 |
ICH5120-50mg |
Labetuzumab Biosimilar – Research Grade |
50mg |
2126 |
ICH5120-5mg |
Labetuzumab Biosimilar – Research Grade |
5mg |
2127 |
ICH5121-100mg |
Necitumumab Biosimilar – Research Grade |
100mg |
2128 |
ICH5121-10mg |
Necitumumab Biosimilar – Research Grade |
10mg |
2129 |
ICH5121-1mg |
Necitumumab Biosimilar – Research Grade |
1mg |
2130 |
ICH5121-20mg |
Necitumumab Biosimilar – Research Grade |
20mg |
2131 |
ICH5121-50mg |
Necitumumab Biosimilar – Research Grade |
50mg |
2132 |
ICH5121-5mg |
Necitumumab Biosimilar – Research Grade |
5mg |
2133 |
ICH5122-100mg |
Tilvestamab Biosimilar – Research Grade |
100mg |
2134 |
ICH5122-10mg |
Tilvestamab Biosimilar – Research Grade |
10mg |
2135 |
ICH5122-1mg |
Tilvestamab Biosimilar – Research Grade |
1mg |
2136 |
ICH5122-20mg |
Tilvestamab Biosimilar – Research Grade |
20mg |
2137 |
ICH5122-50mg |
Tilvestamab Biosimilar – Research Grade |
50mg |
2138 |
ICH5122-5mg |
Tilvestamab Biosimilar – Research Grade |
5mg |
2139 |
ICH5123-100mg |
Nemolizumab Biosimilar – Research Grade |
100mg |
2140 |
ICH5123-10mg |
Nemolizumab Biosimilar – Research Grade |
10mg |
2141 |
ICH5123-1mg |
Nemolizumab Biosimilar – Research Grade |
1mg |
2142 |
ICH5123-20mg |
Nemolizumab Biosimilar – Research Grade |
20mg |
2143 |
ICH5123-50mg |
Nemolizumab Biosimilar – Research Grade |
50mg |
2144 |
ICH5123-5mg |
Nemolizumab Biosimilar – Research Grade |
5mg |
2145 |
ICH5124-100mg |
Enoblituzumab Biosimilar – Research Grade |
100mg |
2146 |
ICH5124-10mg |
Enoblituzumab Biosimilar – Research Grade |
10mg |
2147 |
ICH5124-1mg |
Enoblituzumab Biosimilar – Research Grade |
1mg |
2148 |
ICH5124-20mg |
Enoblituzumab Biosimilar – Research Grade |
20mg |
2149 |
ICH5124-50mg |
Enoblituzumab Biosimilar – Research Grade |
50mg |
2150 |
ICH5124-5mg |
Enoblituzumab Biosimilar – Research Grade |
5mg |
2151 |
ICH5125-100mg |
Tilavonemab Biosimilar – Research Grade |
100mg |
2152 |
ICH5125-10mg |
Tilavonemab Biosimilar – Research Grade |
10mg |
2153 |
ICH5125-1mg |
Tilavonemab Biosimilar – Research Grade |
1mg |
2154 |
ICH5125-20mg |
Tilavonemab Biosimilar – Research Grade |
20mg |
2155 |
ICH5125-50mg |
Tilavonemab Biosimilar – Research Grade |
50mg |
2156 |
ICH5125-5mg |
Tilavonemab Biosimilar – Research Grade |
5mg |
2157 |
ICH5126-100mg |
Zagotenemab Biosimilar – Research Grade |
100mg |
2158 |
ICH5126-10mg |
Zagotenemab Biosimilar – Research Grade |
10mg |
2159 |
ICH5126-1mg |
Zagotenemab Biosimilar – Research Grade |
1mg |
2160 |
ICH5126-20mg |
Zagotenemab Biosimilar – Research Grade |
20mg |
2161 |
ICH5126-50mg |
Zagotenemab Biosimilar – Research Grade |
50mg |
2162 |
ICH5126-5mg |
Zagotenemab Biosimilar – Research Grade |
5mg |
2163 |
ICH5128-100mg |
Teprotumumab Biosimilar – Research Grade |
100mg |
2164 |
ICH5128-10mg |
Teprotumumab Biosimilar – Research Grade |
10mg |
2165 |
ICH5128-1mg |
Teprotumumab Biosimilar – Research Grade |
1mg |
2166 |
ICH5128-20mg |
Teprotumumab Biosimilar – Research Grade |
20mg |
2167 |
ICH5128-50mg |
Teprotumumab Biosimilar – Research Grade |
50mg |
2168 |
ICH5128-5mg |
Teprotumumab Biosimilar – Research Grade |
5mg |
2169 |
ICH5129-100mg |
Lucatumumab Biosimilar – Research Grade |
100mg |
2170 |
ICH5129-10mg |
Lucatumumab Biosimilar – Research Grade |
10mg |
2171 |
ICH5129-1mg |
Lucatumumab Biosimilar – Research Grade |
1mg |
2172 |
ICH5129-20mg |
Lucatumumab Biosimilar – Research Grade |
20mg |
2173 |
ICH5129-50mg |
Lucatumumab Biosimilar – Research Grade |
50mg |
2174 |
ICH5129-5mg |
Lucatumumab Biosimilar – Research Grade |
5mg |
2175 |
ICH5130-100mg |
Anifrolumab Biosimilar – Research Grade |
100mg |
2176 |
ICH5130-10mg |
Anifrolumab Biosimilar – Research Grade |
10mg |
2177 |
ICH5130-1mg |
Anifrolumab Biosimilar – Research Grade |
1mg |
2178 |
ICH5130-20mg |
Anifrolumab Biosimilar – Research Grade |
20mg |
2179 |
ICH5130-50mg |
Anifrolumab Biosimilar – Research Grade |
50mg |
2180 |
ICH5130-5mg |
Anifrolumab Biosimilar – Research Grade |
5mg |
2181 |
ICH5131-100mg |
Uliledlimab Biosimilar – Research Grade |
100mg |
2182 |
ICH5131-10mg |
Uliledlimab Biosimilar – Research Grade |
10mg |
2183 |
ICH5131-1mg |
Uliledlimab Biosimilar – Research Grade |
1mg |
2184 |
ICH5131-20mg |
Uliledlimab Biosimilar – Research Grade |
20mg |
2185 |
ICH5131-50mg |
Uliledlimab Biosimilar – Research Grade |
50mg |
2186 |
ICH5131-5mg |
Uliledlimab Biosimilar – Research Grade |
5mg |
2187 |
ICH5132-100mg |
Tafasitamab Biosimilar – Research Grade |
100mg |
2188 |
ICH5132-10mg |
Tafasitamab Biosimilar – Research Grade |
10mg |
2189 |
ICH5132-1mg |
Tafasitamab Biosimilar – Research Grade |
1mg |
2190 |
ICH5132-20mg |
Tafasitamab Biosimilar – Research Grade |
20mg |
2191 |
ICH5132-50mg |
Tafasitamab Biosimilar – Research Grade |
50mg |
2192 |
ICH5132-5mg |
Tafasitamab Biosimilar – Research Grade |
5mg |
2193 |
ICH5133-100mg |
Gevokizumab Biosimilar – Research Grade |
100mg |
2194 |
ICH5133-10mg |
Gevokizumab Biosimilar – Research Grade |
10mg |
2195 |
ICH5133-1mg |
Gevokizumab Biosimilar – Research Grade |
1mg |
2196 |
ICH5133-20mg |
Gevokizumab Biosimilar – Research Grade |
20mg |
2197 |
ICH5133-50mg |
Gevokizumab Biosimilar – Research Grade |
50mg |
2198 |
ICH5133-5mg |
Gevokizumab Biosimilar – Research Grade |
5mg |
2199 |
ICH5134-100mg |
Enibarcimab Biosimilar – Research Grade |
100mg |
2200 |
ICH5134-10mg |
Enibarcimab Biosimilar – Research Grade |
10mg |
2201 |
ICH5134-1mg |
Enibarcimab Biosimilar – Research Grade |
1mg |
2202 |
ICH5134-20mg |
Enibarcimab Biosimilar – Research Grade |
20mg |
2203 |
ICH5134-50mg |
Enibarcimab Biosimilar – Research Grade |
50mg |
2204 |
ICH5134-5mg |
Enibarcimab Biosimilar – Research Grade |
5mg |
2205 |
ICH5136-100mg |
Mupadolimab Biosimilar – Research Grade |
100mg |
2206 |
ICH5136-10mg |
Mupadolimab Biosimilar – Research Grade |
10mg |
2207 |
ICH5136-1mg |
Mupadolimab Biosimilar – Research Grade |
1mg |
2208 |
ICH5136-20mg |
Mupadolimab Biosimilar – Research Grade |
20mg |
2209 |
ICH5136-50mg |
Mupadolimab Biosimilar – Research Grade |
50mg |
2210 |
ICH5136-5mg |
Mupadolimab Biosimilar – Research Grade |
5mg |
2211 |
ICH5137-100mg |
Brentuximab Biosimilar – Research Grade |
100mg |
2212 |
ICH5137-10mg |
Brentuximab Biosimilar – Research Grade |
10mg |
2213 |
ICH5137-1mg |
Brentuximab Biosimilar – Research Grade |
1mg |
2214 |
ICH5137-20mg |
Brentuximab Biosimilar – Research Grade |
20mg |
2215 |
ICH5137-50mg |
Brentuximab Biosimilar – Research Grade |
50mg |
2216 |
ICH5137-5mg |
Brentuximab Biosimilar – Research Grade |
5mg |
2217 |
ICH5138-100mg |
Abituzumab Biosimilar – Research Grade |
100mg |
2218 |
ICH5138-10mg |
Abituzumab Biosimilar – Research Grade |
10mg |
2219 |
ICH5138-1mg |
Abituzumab Biosimilar – Research Grade |
1mg |
2220 |
ICH5138-20mg |
Abituzumab Biosimilar – Research Grade |
20mg |
2221 |
ICH5138-50mg |
Abituzumab Biosimilar – Research Grade |
50mg |
2222 |
ICH5138-5mg |
Abituzumab Biosimilar – Research Grade |
5mg |
2223 |
ICH5139-100mg |
Abrilumab Biosimilar – Research Grade |
100mg |
2224 |
ICH5139-10mg |
Abrilumab Biosimilar – Research Grade |
10mg |
2225 |
ICH5139-1mg |
Abrilumab Biosimilar – Research Grade |
1mg |
2226 |
ICH5139-20mg |
Abrilumab Biosimilar – Research Grade |
20mg |
2227 |
ICH5139-50mg |
Abrilumab Biosimilar – Research Grade |
50mg |
2228 |
ICH5139-5mg |
Abrilumab Biosimilar – Research Grade |
5mg |
2229 |
ICH5140-100mg |
Bapineuzumab Biosimilar – Research Grade |
100mg |
2230 |
ICH5140-10mg |
Bapineuzumab Biosimilar – Research Grade |
10mg |
2231 |
ICH5140-1mg |
Bapineuzumab Biosimilar – Research Grade |
1mg |
2232 |
ICH5140-20mg |
Bapineuzumab Biosimilar – Research Grade |
20mg |
2233 |
ICH5140-50mg |
Bapineuzumab Biosimilar – Research Grade |
50mg |
2234 |
ICH5140-5mg |
Bapineuzumab Biosimilar – Research Grade |
5mg |
2235 |
ICH5141-100mg |
Blosozumab Biosimilar – Research Grade |
100mg |
2236 |
ICH5141-10mg |
Blosozumab Biosimilar – Research Grade |
10mg |
2237 |
ICH5141-1mg |
Blosozumab Biosimilar – Research Grade |
1mg |
2238 |
ICH5141-20mg |
Blosozumab Biosimilar – Research Grade |
20mg |
2239 |
ICH5141-50mg |
Blosozumab Biosimilar – Research Grade |
50mg |
2240 |
ICH5141-5mg |
Blosozumab Biosimilar – Research Grade |
5mg |
2241 |
ICH5142-100mg |
Bococizumab Biosimilar – Research Grade |
100mg |
2242 |
ICH5142-10mg |
Bococizumab Biosimilar – Research Grade |
10mg |
2243 |
ICH5142-1mg |
Bococizumab Biosimilar – Research Grade |
1mg |
2244 |
ICH5142-20mg |
Bococizumab Biosimilar – Research Grade |
20mg |
2245 |
ICH5142-50mg |
Bococizumab Biosimilar – Research Grade |
50mg |
2246 |
ICH5142-5mg |
Bococizumab Biosimilar – Research Grade |
5mg |
2247 |
ICH5143-100mg |
Carlumab Biosimilar – Research Grade |
100mg |
2248 |
ICH5143-10mg |
Carlumab Biosimilar – Research Grade |
10mg |
2249 |
ICH5143-1mg |
Carlumab Biosimilar – Research Grade |
1mg |
2250 |
ICH5143-20mg |
Carlumab Biosimilar – Research Grade |
20mg |
2251 |
ICH5143-50mg |
Carlumab Biosimilar – Research Grade |
50mg |
2252 |
ICH5143-5mg |
Carlumab Biosimilar – Research Grade |
5mg |
2253 |
ICH5144-100mg |
Cixutumumab Biosimilar – Research Grade |
100mg |
2254 |
ICH5144-10mg |
Cixutumumab Biosimilar – Research Grade |
10mg |
2255 |
ICH5144-1mg |
Cixutumumab Biosimilar – Research Grade |
1mg |
2256 |
ICH5144-20mg |
Cixutumumab Biosimilar – Research Grade |
20mg |
2257 |
ICH5144-50mg |
Cixutumumab Biosimilar – Research Grade |
50mg |
2258 |
ICH5144-5mg |
Cixutumumab Biosimilar – Research Grade |
5mg |
2259 |
ICH5145-100mg |
Efalizumab Biosimilar – Research Grade |
100mg |
2260 |
ICH5145-10mg |
Efalizumab Biosimilar – Research Grade |
10mg |
2261 |
ICH5145-1mg |
Efalizumab Biosimilar – Research Grade |
1mg |
2262 |
ICH5145-20mg |
Efalizumab Biosimilar – Research Grade |
20mg |
2263 |
ICH5145-50mg |
Efalizumab Biosimilar – Research Grade |
50mg |
2264 |
ICH5145-5mg |
Efalizumab Biosimilar – Research Grade |
5mg |
2265 |
ICH5146-100mg |
Eldelumab Biosimilar – Research Grade |
100mg |
2266 |
ICH5146-10mg |
Eldelumab Biosimilar – Research Grade |
10mg |
2267 |
ICH5146-1mg |
Eldelumab Biosimilar – Research Grade |
1mg |
2268 |
ICH5146-20mg |
Eldelumab Biosimilar – Research Grade |
20mg |
2269 |
ICH5146-50mg |
Eldelumab Biosimilar – Research Grade |
50mg |
2270 |
ICH5146-5mg |
Eldelumab Biosimilar – Research Grade |
5mg |
2271 |
ICH5147-100mg |
Emapalumab Biosimilar – Research Grade |
100mg |
2272 |
ICH5147-10mg |
Emapalumab Biosimilar – Research Grade |
10mg |
2273 |
ICH5147-1mg |
Emapalumab Biosimilar – Research Grade |
1mg |
2274 |
ICH5147-20mg |
Emapalumab Biosimilar – Research Grade |
20mg |
2275 |
ICH5147-50mg |
Emapalumab Biosimilar – Research Grade |
50mg |
2276 |
ICH5147-5mg |
Emapalumab Biosimilar – Research Grade |
5mg |
2277 |
ICH5148-100mg |
Emibetuzumab Biosimilar – Research Grade |
100mg |
2278 |
ICH5148-10mg |
Emibetuzumab Biosimilar – Research Grade |
10mg |
2279 |
ICH5148-1mg |
Emibetuzumab Biosimilar – Research Grade |
1mg |
2280 |
ICH5148-20mg |
Emibetuzumab Biosimilar – Research Grade |
20mg |
2281 |
ICH5148-50mg |
Emibetuzumab Biosimilar – Research Grade |
50mg |
2282 |
ICH5148-5mg |
Emibetuzumab Biosimilar – Research Grade |
5mg |
2283 |
ICH5149-100mg |
Enokizumab Biosimilar – Research Grade |
100mg |
2284 |
ICH5149-10mg |
Enokizumab Biosimilar – Research Grade |
10mg |
2285 |
ICH5149-1mg |
Enokizumab Biosimilar – Research Grade |
1mg |
2286 |
ICH5149-20mg |
Enokizumab Biosimilar – Research Grade |
20mg |
2287 |
ICH5149-50mg |
Enokizumab Biosimilar – Research Grade |
50mg |
2288 |
ICH5149-5mg |
Enokizumab Biosimilar – Research Grade |
5mg |
2289 |
ICH5150-100mg |
Etrolizumab Biosimilar – Research Grade |
100mg |
2290 |
ICH5150-10mg |
Etrolizumab Biosimilar – Research Grade |
10mg |
2291 |
ICH5150-1mg |
Etrolizumab Biosimilar – Research Grade |
1mg |
2292 |
ICH5150-20mg |
Etrolizumab Biosimilar – Research Grade |
20mg |
2293 |
ICH5150-50mg |
Etrolizumab Biosimilar – Research Grade |
50mg |
2294 |
ICH5150-5mg |
Etrolizumab Biosimilar – Research Grade |
5mg |
2295 |
ICH5151-100mg |
Evinacumab Biosimilar – Research Grade |
100mg |
2296 |
ICH5151-10mg |
Evinacumab Biosimilar – Research Grade |
10mg |
2297 |
ICH5151-1mg |
Evinacumab Biosimilar – Research Grade |
1mg |
2298 |
ICH5151-20mg |
Evinacumab Biosimilar – Research Grade |
20mg |
2299 |
ICH5151-50mg |
Evinacumab Biosimilar – Research Grade |
50mg |
2300 |
ICH5151-5mg |
Evinacumab Biosimilar – Research Grade |
5mg |
2301 |
ICH5152-100mg |
Fasinumab Biosimilar – Research Grade |
100mg |
2302 |
ICH5152-10mg |
Fasinumab Biosimilar – Research Grade |
10mg |
2303 |
ICH5152-1mg |
Fasinumab Biosimilar – Research Grade |
1mg |
2304 |
ICH5152-20mg |
Fasinumab Biosimilar – Research Grade |
20mg |
2305 |
ICH5152-50mg |
Fasinumab Biosimilar – Research Grade |
50mg |
2306 |
ICH5152-5mg |
Fasinumab Biosimilar – Research Grade |
5mg |
2307 |
ICH5153-100mg |
Ficlatuzumab Biosimilar – Research Grade |
100mg |
2308 |
ICH5153-10mg |
Ficlatuzumab Biosimilar – Research Grade |
10mg |
2309 |
ICH5153-1mg |
Ficlatuzumab Biosimilar – Research Grade |
1mg |
2310 |
ICH5153-20mg |
Ficlatuzumab Biosimilar – Research Grade |
20mg |
2311 |
ICH5153-50mg |
Ficlatuzumab Biosimilar – Research Grade |
50mg |
2312 |
ICH5153-5mg |
Ficlatuzumab Biosimilar – Research Grade |
5mg |
2313 |
ICH5154-100mg |
Figitumumab Biosimilar – Research Grade |
100mg |
2314 |
ICH5154-10mg |
Figitumumab Biosimilar – Research Grade |
10mg |
2315 |
ICH5154-1mg |
Figitumumab Biosimilar – Research Grade |
1mg |
2316 |
ICH5154-20mg |
Figitumumab Biosimilar – Research Grade |
20mg |
2317 |
ICH5154-50mg |
Figitumumab Biosimilar – Research Grade |
50mg |
2318 |
ICH5154-5mg |
Figitumumab Biosimilar – Research Grade |
5mg |
2319 |
ICH5155-100mg |
Fletikumab Biosimilar – Research Grade |
100mg |
2320 |
ICH5155-10mg |
Fletikumab Biosimilar – Research Grade |
10mg |
2321 |
ICH5155-1mg |
Fletikumab Biosimilar – Research Grade |
1mg |
2322 |
ICH5155-20mg |
Fletikumab Biosimilar – Research Grade |
20mg |
2323 |
ICH5155-50mg |
Fletikumab Biosimilar – Research Grade |
50mg |
2324 |
ICH5155-5mg |
Fletikumab Biosimilar – Research Grade |
5mg |
2325 |
ICH5156-100mg |
Foralumab Biosimilar – Research Grade |
100mg |
2326 |
ICH5156-10mg |
Foralumab Biosimilar – Research Grade |
10mg |
2327 |
ICH5156-1mg |
Foralumab Biosimilar – Research Grade |
1mg |
2328 |
ICH5156-20mg |
Foralumab Biosimilar – Research Grade |
20mg |
2329 |
ICH5156-50mg |
Foralumab Biosimilar – Research Grade |
50mg |
2330 |
ICH5156-5mg |
Foralumab Biosimilar – Research Grade |
5mg |
2331 |
ICH5157-100mg |
Fulranumab Biosimilar – Research Grade |
100mg |
2332 |
ICH5157-10mg |
Fulranumab Biosimilar – Research Grade |
10mg |
2333 |
ICH5157-1mg |
Fulranumab Biosimilar – Research Grade |
1mg |
2334 |
ICH5157-20mg |
Fulranumab Biosimilar – Research Grade |
20mg |
2335 |
ICH5157-50mg |
Fulranumab Biosimilar – Research Grade |
50mg |
2336 |
ICH5157-5mg |
Fulranumab Biosimilar – Research Grade |
5mg |
2337 |
ICH5158-100mg |
Zilovertamab Biosimilar – Research Grade |
100mg |
2338 |
ICH5158-10mg |
Zilovertamab Biosimilar – Research Grade |
10mg |
2339 |
ICH5158-1mg |
Zilovertamab Biosimilar – Research Grade |
1mg |
2340 |
ICH5158-20mg |
Zilovertamab Biosimilar – Research Grade |
20mg |
2341 |
ICH5158-50mg |
Zilovertamab Biosimilar – Research Grade |
50mg |
2342 |
ICH5158-5mg |
Zilovertamab Biosimilar – Research Grade |
5mg |
2343 |
ICH5159-100mg |
Vibostolimab Biosimilar – Research Grade |
100mg |
2344 |
ICH5159-10mg |
Vibostolimab Biosimilar – Research Grade |
10mg |
2345 |
ICH5159-1mg |
Vibostolimab Biosimilar – Research Grade |
1mg |
2346 |
ICH5159-20mg |
Vibostolimab Biosimilar – Research Grade |
20mg |
2347 |
ICH5159-50mg |
Vibostolimab Biosimilar – Research Grade |
50mg |
2348 |
ICH5159-5mg |
Vibostolimab Biosimilar – Research Grade |
5mg |
2349 |
ICH5160-100mg |
Burosumab Biosimilar – Research Grade |
100mg |
2350 |
ICH5160-10mg |
Burosumab Biosimilar – Research Grade |
10mg |
2351 |
ICH5160-1mg |
Burosumab Biosimilar – Research Grade |
1mg |
2352 |
ICH5160-20mg |
Burosumab Biosimilar – Research Grade |
20mg |
2353 |
ICH5160-50mg |
Burosumab Biosimilar – Research Grade |
50mg |
2354 |
ICH5160-5mg |
Burosumab Biosimilar – Research Grade |
5mg |
2355 |
ICH5161-100mg |
Cemiplimab Biosimilar – Research Grade |
100mg |
2356 |
ICH5161-10mg |
Cemiplimab Biosimilar – Research Grade |
10mg |
2357 |
ICH5161-1mg |
Cemiplimab Biosimilar – Research Grade |
1mg |
2358 |
ICH5161-20mg |
Cemiplimab Biosimilar – Research Grade |
20mg |
2359 |
ICH5161-50mg |
Cemiplimab Biosimilar – Research Grade |
50mg |
2360 |
ICH5161-5mg |
Cemiplimab Biosimilar – Research Grade |
5mg |
2361 |
ICH5163-100mg |
Glembatumumab Biosimilar – Research Grade |
100mg |
2362 |
ICH5163-10mg |
Glembatumumab Biosimilar – Research Grade |
10mg |
2363 |
ICH5163-1mg |
Glembatumumab Biosimilar – Research Grade |
1mg |
2364 |
ICH5163-20mg |
Glembatumumab Biosimilar – Research Grade |
20mg |
2365 |
ICH5163-50mg |
Glembatumumab Biosimilar – Research Grade |
50mg |
2366 |
ICH5163-5mg |
Glembatumumab Biosimilar – Research Grade |
5mg |
2367 |
ICH5164-100mg |
Naxitamab Biosimilar – Research Grade |
100mg |
2368 |
ICH5164-10mg |
Naxitamab Biosimilar – Research Grade |
10mg |
2369 |
ICH5164-1mg |
Naxitamab Biosimilar – Research Grade |
1mg |
2370 |
ICH5164-20mg |
Naxitamab Biosimilar – Research Grade |
20mg |
2371 |
ICH5164-50mg |
Naxitamab Biosimilar – Research Grade |
50mg |
2372 |
ICH5164-5mg |
Naxitamab Biosimilar – Research Grade |
5mg |
2373 |
ICH5165-100mg |
Ixekizumab Biosimilar – Research Grade |
100mg |
2374 |
ICH5165-10mg |
Ixekizumab Biosimilar – Research Grade |
10mg |
2375 |
ICH5165-1mg |
Ixekizumab Biosimilar – Research Grade |
1mg |
2376 |
ICH5165-20mg |
Ixekizumab Biosimilar – Research Grade |
20mg |
2377 |
ICH5165-50mg |
Ixekizumab Biosimilar – Research Grade |
50mg |
2378 |
ICH5165-5mg |
Ixekizumab Biosimilar – Research Grade |
5mg |
2379 |
ICH5166-100mg |
Lenzilumab Biosimilar – Research Grade |
100mg |
2380 |
ICH5166-10mg |
Lenzilumab Biosimilar – Research Grade |
10mg |
2381 |
ICH5166-1mg |
Lenzilumab Biosimilar – Research Grade |
1mg |
2382 |
ICH5166-20mg |
Lenzilumab Biosimilar – Research Grade |
20mg |
2383 |
ICH5166-50mg |
Lenzilumab Biosimilar – Research Grade |
50mg |
2384 |
ICH5166-5mg |
Lenzilumab Biosimilar – Research Grade |
5mg |
2385 |
ICH5167-100mg |
Lirilumab Biosimilar – Research Grade |
100mg |
2386 |
ICH5167-10mg |
Lirilumab Biosimilar – Research Grade |
10mg |
2387 |
ICH5167-1mg |
Lirilumab Biosimilar – Research Grade |
1mg |
2388 |
ICH5167-20mg |
Lirilumab Biosimilar – Research Grade |
20mg |
2389 |
ICH5167-50mg |
Lirilumab Biosimilar – Research Grade |
50mg |
2390 |
ICH5167-5mg |
Lirilumab Biosimilar – Research Grade |
5mg |
2391 |
ICH5168-100mg |
Inebilizumab Biosimilar – Research Grade |
100mg |
2392 |
ICH5168-10mg |
Inebilizumab Biosimilar – Research Grade |
10mg |
2393 |
ICH5168-1mg |
Inebilizumab Biosimilar – Research Grade |
1mg |
2394 |
ICH5168-20mg |
Inebilizumab Biosimilar – Research Grade |
20mg |
2395 |
ICH5168-50mg |
Inebilizumab Biosimilar – Research Grade |
50mg |
2396 |
ICH5168-5mg |
Inebilizumab Biosimilar – Research Grade |
5mg |
2397 |
ICH5169-100mg |
Motavizumab Biosimilar – Research Grade |
100mg |
2398 |
ICH5169-10mg |
Motavizumab Biosimilar – Research Grade |
10mg |
2399 |
ICH5169-1mg |
Motavizumab Biosimilar – Research Grade |
1mg |
2400 |
ICH5169-20mg |
Motavizumab Biosimilar – Research Grade |
20mg |
2401 |
ICH5169-50mg |
Motavizumab Biosimilar – Research Grade |
50mg |
2402 |
ICH5169-5mg |
Motavizumab Biosimilar – Research Grade |
5mg |
2403 |
ICH5170-100mg |
Olokizumab Biosimilar – Research Grade |
100mg |
2404 |
ICH5170-10mg |
Olokizumab Biosimilar – Research Grade |
10mg |
2405 |
ICH5170-1mg |
Olokizumab Biosimilar – Research Grade |
1mg |
2406 |
ICH5170-20mg |
Olokizumab Biosimilar – Research Grade |
20mg |
2407 |
ICH5170-50mg |
Olokizumab Biosimilar – Research Grade |
50mg |
2408 |
ICH5170-5mg |
Olokizumab Biosimilar – Research Grade |
5mg |
2409 |
ICH5171-100mg |
Otelixizumab Biosimilar – Research Grade |
100mg |
2410 |
ICH5171-10mg |
Otelixizumab Biosimilar – Research Grade |
10mg |
2411 |
ICH5171-1mg |
Otelixizumab Biosimilar – Research Grade |
1mg |
2412 |
ICH5171-20mg |
Otelixizumab Biosimilar – Research Grade |
20mg |
2413 |
ICH5171-50mg |
Otelixizumab Biosimilar – Research Grade |
50mg |
2414 |
ICH5171-5mg |
Otelixizumab Biosimilar – Research Grade |
5mg |
2415 |
ICH5172-100mg |
Otlertuzumab Biosimilar – Research Grade |
100mg |
2416 |
ICH5172-10mg |
Otlertuzumab Biosimilar – Research Grade |
10mg |
2417 |
ICH5172-1mg |
Otlertuzumab Biosimilar – Research Grade |
1mg |
2418 |
ICH5172-20mg |
Otlertuzumab Biosimilar – Research Grade |
20mg |
2419 |
ICH5172-50mg |
Otlertuzumab Biosimilar – Research Grade |
50mg |
2420 |
ICH5172-5mg |
Otlertuzumab Biosimilar – Research Grade |
5mg |
2421 |
ICH5173-100mg |
Ozanezumab Biosimilar – Research Grade |
100mg |
2422 |
ICH5173-10mg |
Ozanezumab Biosimilar – Research Grade |
10mg |
2423 |
ICH5173-1mg |
Ozanezumab Biosimilar – Research Grade |
1mg |
2424 |
ICH5173-20mg |
Ozanezumab Biosimilar – Research Grade |
20mg |
2425 |
ICH5173-50mg |
Ozanezumab Biosimilar – Research Grade |
50mg |
2426 |
ICH5173-5mg |
Ozanezumab Biosimilar – Research Grade |
5mg |
2427 |
ICH5174-100mg |
Panobacumab Biosimilar – Research Grade |
100mg |
2428 |
ICH5174-10mg |
Panobacumab Biosimilar – Research Grade |
10mg |
2429 |
ICH5174-1mg |
Panobacumab Biosimilar – Research Grade |
1mg |
2430 |
ICH5174-20mg |
Panobacumab Biosimilar – Research Grade |
20mg |
2431 |
ICH5174-50mg |
Panobacumab Biosimilar – Research Grade |
50mg |
2432 |
ICH5174-5mg |
Panobacumab Biosimilar – Research Grade |
5mg |
2433 |
ICH5175-100mg |
Parsatuzumab Biosimilar – Research Grade |
100mg |
2434 |
ICH5175-10mg |
Parsatuzumab Biosimilar – Research Grade |
10mg |
2435 |
ICH5175-1mg |
Parsatuzumab Biosimilar – Research Grade |
1mg |
2436 |
ICH5175-20mg |
Parsatuzumab Biosimilar – Research Grade |
20mg |
2437 |
ICH5175-50mg |
Parsatuzumab Biosimilar – Research Grade |
50mg |
2438 |
ICH5175-5mg |
Parsatuzumab Biosimilar – Research Grade |
5mg |
2439 |
ICH5176-100mg |
Fezakinumab Biosimilar – Research Grade |
100mg |
2440 |
ICH5176-10mg |
Fezakinumab Biosimilar – Research Grade |
10mg |
2441 |
ICH5176-1mg |
Fezakinumab Biosimilar – Research Grade |
1mg |
2442 |
ICH5176-20mg |
Fezakinumab Biosimilar – Research Grade |
20mg |
2443 |
ICH5176-50mg |
Fezakinumab Biosimilar – Research Grade |
50mg |
2444 |
ICH5176-5mg |
Fezakinumab Biosimilar – Research Grade |
5mg |
2445 |
ICH5177-100mg |
Envafolimab Biosimilar – Research Grade |
100mg |
2446 |
ICH5177-10mg |
Envafolimab Biosimilar – Research Grade |
10mg |
2447 |
ICH5177-1mg |
Envafolimab Biosimilar – Research Grade |
1mg |
2448 |
ICH5177-20mg |
Envafolimab Biosimilar – Research Grade |
20mg |
2449 |
ICH5177-50mg |
Envafolimab Biosimilar – Research Grade |
50mg |
2450 |
ICH5177-5mg |
Envafolimab Biosimilar – Research Grade |
5mg |
2451 |
ICH5178-100mg |
Emicizumab Biosimilar – Research Grade |
100mg |
2452 |
ICH5178-10mg |
Emicizumab Biosimilar – Research Grade |
10mg |
2453 |
ICH5178-1mg |
Emicizumab Biosimilar – Research Grade |
1mg |
2454 |
ICH5178-20mg |
Emicizumab Biosimilar – Research Grade |
20mg |
2455 |
ICH5178-50mg |
Emicizumab Biosimilar – Research Grade |
50mg |
2456 |
ICH5178-5mg |
Emicizumab Biosimilar – Research Grade |
5mg |
2457 |
ICH5179-100mg |
Ozuriftamab Biosimilar – Research Grade |
100mg |
2458 |
ICH5179-10mg |
Ozuriftamab Biosimilar – Research Grade |
10mg |
2459 |
ICH5179-1mg |
Ozuriftamab Biosimilar – Research Grade |
1mg |
2460 |
ICH5179-20mg |
Ozuriftamab Biosimilar – Research Grade |
20mg |
2461 |
ICH5179-50mg |
Ozuriftamab Biosimilar – Research Grade |
50mg |
2462 |
ICH5179-5mg |
Ozuriftamab Biosimilar – Research Grade |
5mg |
2463 |
ICH5180-100mg |
Bamlanivimab Biosimilar – Research Grade |
100mg |
2464 |
ICH5180-10mg |
Bamlanivimab Biosimilar – Research Grade |
10mg |
2465 |
ICH5180-1mg |
Bamlanivimab Biosimilar – Research Grade |
1mg |
2466 |
ICH5180-20mg |
Bamlanivimab Biosimilar – Research Grade |
20mg |
2467 |
ICH5180-50mg |
Bamlanivimab Biosimilar – Research Grade |
50mg |
2468 |
ICH5180-5mg |
Bamlanivimab Biosimilar – Research Grade |
5mg |
2469 |
ICH5181-100mg |
Alsevalimab Biosimilar – Research Grade |
100mg |
2470 |
ICH5181-10mg |
Alsevalimab Biosimilar – Research Grade |
10mg |
2471 |
ICH5181-1mg |
Alsevalimab Biosimilar – Research Grade |
1mg |
2472 |
ICH5181-20mg |
Alsevalimab Biosimilar – Research Grade |
20mg |
2473 |
ICH5181-50mg |
Alsevalimab Biosimilar – Research Grade |
50mg |
2474 |
ICH5181-5mg |
Alsevalimab Biosimilar – Research Grade |
5mg |
2475 |
ICH5182-100mg |
Ponsegromab Biosimilar – Research Grade |
100mg |
2476 |
ICH5182-10mg |
Ponsegromab Biosimilar – Research Grade |
10mg |
2477 |
ICH5182-1mg |
Ponsegromab Biosimilar – Research Grade |
1mg |
2478 |
ICH5182-20mg |
Ponsegromab Biosimilar – Research Grade |
20mg |
2479 |
ICH5182-50mg |
Ponsegromab Biosimilar – Research Grade |
50mg |
2480 |
ICH5182-5mg |
Ponsegromab Biosimilar – Research Grade |
5mg |
2481 |
ICH5183-100mg |
Lusvertikimab Biosimilar – Research Grade |
100mg |
2482 |
ICH5183-10mg |
Lusvertikimab Biosimilar – Research Grade |
10mg |
2483 |
ICH5183-1mg |
Lusvertikimab Biosimilar – Research Grade |
1mg |
2484 |
ICH5183-20mg |
Lusvertikimab Biosimilar – Research Grade |
20mg |
2485 |
ICH5183-50mg |
Lusvertikimab Biosimilar – Research Grade |
50mg |
2486 |
ICH5183-5mg |
Lusvertikimab Biosimilar – Research Grade |
5mg |
2487 |
ICH5184-100mg |
Tremelimumab Biosimilar – Research Grade |
100mg |
2488 |
ICH5184-10mg |
Tremelimumab Biosimilar – Research Grade |
10mg |
2489 |
ICH5184-1mg |
Tremelimumab Biosimilar – Research Grade |
1mg |
2490 |
ICH5184-20mg |
Tremelimumab Biosimilar – Research Grade |
20mg |
2491 |
ICH5184-50mg |
Tremelimumab Biosimilar – Research Grade |
50mg |
2492 |
ICH5184-5mg |
Tremelimumab Biosimilar – Research Grade |
5mg |
2493 |
ICH5185-10mg |
Abatacept Biosimilar – Research Grade |
10mg |
2494 |
ICH5185-1mg |
Abatacept Biosimilar – Research Grade |
1mg |
2495 |
ICH5185-20mg |
Abatacept Biosimilar – Research Grade |
20mg |
2496 |
ICH5185-5mg |
Abatacept Biosimilar – Research Grade |
5mg |
2497 |
ICH5186-100mg |
Mogamulizumab Biosimilar – Research Grade |
100mg |
2498 |
ICH5186-10mg |
Mogamulizumab Biosimilar – Research Grade |
10mg |
2499 |
ICH5186-1mg |
Mogamulizumab Biosimilar – Research Grade |
1mg |
2500 |
ICH5186-20mg |
Mogamulizumab Biosimilar – Research Grade |
20mg |
2501 |
ICH5186-50mg |
Mogamulizumab Biosimilar – Research Grade |
50mg |
2502 |
ICH5186-5mg |
Mogamulizumab Biosimilar – Research Grade |
5mg |
2503 |
ICH5186B-0.1mg |
Mogamulizumab Biosimilar – Biotin Research Grade |
100ug |
2504 |
ICH5186HRP-0.1mg |
Mogamulizumab Biosimilar – HRP Research Grade |
100ug |
2505 |
ICH5187-100mg |
Oxelumab Biosimilar – Research Grade |
100mg |
2506 |
ICH5187-10mg |
Oxelumab Biosimilar – Research Grade |
10mg |
2507 |
ICH5187-1mg |
Oxelumab Biosimilar – Research Grade |
1mg |
2508 |
ICH5187-20mg |
Oxelumab Biosimilar – Research Grade |
20mg |
2509 |
ICH5187-50mg |
Oxelumab Biosimilar – Research Grade |
50mg |
2510 |
ICH5187-5mg |
Oxelumab Biosimilar – Research Grade |
5mg |
2511 |
ICH5187APC-50ug |
Oxelumab Biosimilar – APC Research Grade |
50ug |
2512 |
ICH5187D488-0.1mg |
Oxelumab Biosimilar – Dylight488 Research Grade |
100ug |
2513 |
ICH5188-100mg |
Briakinumab Biosimilar – Research Grade |
100mg |
2514 |
ICH5188-10mg |
Briakinumab Biosimilar – Research Grade |
10mg |
2515 |
ICH5188-1mg |
Briakinumab Biosimilar – Research Grade |
1mg |
2516 |
ICH5188-20mg |
Briakinumab Biosimilar – Research Grade |
20mg |
2517 |
ICH5188-50mg |
Briakinumab Biosimilar – Research Grade |
50mg |
2518 |
ICH5188-5mg |
Briakinumab Biosimilar – Research Grade |
5mg |
2519 |
ICH5188APC-50ug |
Briakinumab Biosimilar – APC Research Grade |
50ug |
2520 |
ICH5188B-0.1mg |
Briakinumab Biosimilar – Biotin Research Grade |
100ug |
2521 |
ICH5188D488-0.1mg |
Briakinumab Biosimilar – Dylight488 Research Grade |
100ug |
2522 |
ICH5188HRP-0.1mg |
Briakinumab Biosimilar – HRP Research Grade |
100ug |
2523 |
ICH5188PE-50ug |
Briakinumab Biosimilar – PE Research Grade |
50ug |
2524 |
ICH5189-100mg |
Basiliximab Biosimilar – Research Grade |
100mg |
2525 |
ICH5189-10mg |
Basiliximab Biosimilar – Research Grade |
10mg |
2526 |
ICH5189-1mg |
Basiliximab Biosimilar – Research Grade |
1mg |
2527 |
ICH5189-20mg |
Basiliximab Biosimilar – Research Grade |
20mg |
2528 |
ICH5189-50mg |
Basiliximab Biosimilar – Research Grade |
50mg |
2529 |
ICH5189-5mg |
Basiliximab Biosimilar – Research Grade |
5mg |
2530 |
ICH5189D488-0.1mg |
Basiliximab Biosimilar – Dylight488 Research Grade |
100ug |
2531 |
ICH5189PE-50ug |
Basiliximab Biosimilar – PE Research Grade |
50ug |
2532 |
ICH5190-100mg |
Minretumomab Biosimilar – Research Grade |
100mg |
2533 |
ICH5190-10mg |
Minretumomab Biosimilar – Research Grade |
10mg |
2534 |
ICH5190-1mg |
Minretumomab Biosimilar – Research Grade |
1mg |
2535 |
ICH5190-20mg |
Minretumomab Biosimilar – Research Grade |
20mg |
2536 |
ICH5190-50mg |
Minretumomab Biosimilar – Research Grade |
50mg |
2537 |
ICH5190-5mg |
Minretumomab Biosimilar – Research Grade |
5mg |
2538 |
ICH5192-10mg |
Belatacept Biosimilar – Research Grade |
10mg |
2539 |
ICH5192-1mg |
Belatacept Biosimilar – Research Grade |
1mg |
2540 |
ICH5192-20mg |
Belatacept Biosimilar – Research Grade |
20mg |
2541 |
ICH5192-5mg |
Belatacept Biosimilar – Research Grade |
5mg |
2542 |
ICH5193-100mg |
Clenoliximab Biosimilar – Research Grade |
100mg |
2543 |
ICH5193-10mg |
Clenoliximab Biosimilar – Research Grade |
10mg |
2544 |
ICH5193-1mg |
Clenoliximab Biosimilar – Research Grade |
1mg |
2545 |
ICH5193-20mg |
Clenoliximab Biosimilar – Research Grade |
20mg |
2546 |
ICH5193-50mg |
Clenoliximab Biosimilar – Research Grade |
50mg |
2547 |
ICH5193-5mg |
Clenoliximab Biosimilar – Research Grade |
5mg |
2548 |
ICH5194-100mg |
Epratuzumab Biosimilar – Research Grade |
100mg |
2549 |
ICH5194-10mg |
Epratuzumab Biosimilar – Research Grade |
10mg |
2550 |
ICH5194-1mg |
Epratuzumab Biosimilar – Research Grade |
1mg |
2551 |
ICH5194-20mg |
Epratuzumab Biosimilar – Research Grade |
20mg |
2552 |
ICH5194-50mg |
Epratuzumab Biosimilar – Research Grade |
50mg |
2553 |
ICH5194-5mg |
Epratuzumab Biosimilar – Research Grade |
5mg |
2554 |
ICH5196-100mg |
Galiximab Biosimilar – Research Grade |
100mg |
2555 |
ICH5196-10mg |
Galiximab Biosimilar – Research Grade |
10mg |
2556 |
ICH5196-1mg |
Galiximab Biosimilar – Research Grade |
1mg |
2557 |
ICH5196-20mg |
Galiximab Biosimilar – Research Grade |
20mg |
2558 |
ICH5196-50mg |
Galiximab Biosimilar – Research Grade |
50mg |
2559 |
ICH5196-5mg |
Galiximab Biosimilar – Research Grade |
5mg |
2560 |
ICH5200-100mg |
Casirivimab Biosimilar – Research Grade |
100mg |
2561 |
ICH5200-10mg |
Casirivimab Biosimilar – Research Grade |
10mg |
2562 |
ICH5200-1mg |
Casirivimab Biosimilar – Research Grade |
1mg |
2563 |
ICH5200-20mg |
Casirivimab Biosimilar – Research Grade |
20mg |
2564 |
ICH5200-50mg |
Casirivimab Biosimilar – Research Grade |
50mg |
2565 |
ICH5200-5mg |
Casirivimab Biosimilar – Research Grade |
5mg |
2566 |
ICH5201-100mg |
Sotrovimab Biosimilar – Research Grade |
100mg |
2567 |
ICH5201-10mg |
Sotrovimab Biosimilar – Research Grade |
10mg |
2568 |
ICH5201-1mg |
Sotrovimab Biosimilar – Research Grade |
1mg |
2569 |
ICH5201-20mg |
Sotrovimab Biosimilar – Research Grade |
20mg |
2570 |
ICH5201-50mg |
Sotrovimab Biosimilar – Research Grade |
50mg |
2571 |
ICH5201-5mg |
Sotrovimab Biosimilar – Research Grade |
5mg |
2572 |
ICH5202-100mg |
Elotuzumab Biosimilar – Research Grade |
100mg |
2573 |
ICH5202-10mg |
Elotuzumab Biosimilar – Research Grade |
10mg |
2574 |
ICH5202-1mg |
Elotuzumab Biosimilar – Research Grade |
1mg |
2575 |
ICH5202-20mg |
Elotuzumab Biosimilar – Research Grade |
20mg |
2576 |
ICH5202-50mg |
Elotuzumab Biosimilar – Research Grade |
50mg |
2577 |
ICH5202-5mg |
Elotuzumab Biosimilar – Research Grade |
5mg |
2578 |
ICH5203-100mg |
Bavunalimab Biosimilar – Research Grade |
100mg |
2579 |
ICH5203-10mg |
Bavunalimab Biosimilar – Research Grade |
10mg |
2580 |
ICH5203-1mg |
Bavunalimab Biosimilar – Research Grade |
1mg |
2581 |
ICH5203-20mg |
Bavunalimab Biosimilar – Research Grade |
20mg |
2582 |
ICH5203-50mg |
Bavunalimab Biosimilar – Research Grade |
50mg |
2583 |
ICH5203-5mg |
Bavunalimab Biosimilar – Research Grade |
5mg |
2584 |
ICH5204-100mg |
Ifinatamab Biosimilar – Research Grade |
100mg |
2585 |
ICH5204-10mg |
Ifinatamab Biosimilar – Research Grade |
10mg |
2586 |
ICH5204-1mg |
Ifinatamab Biosimilar – Research Grade |
1mg |
2587 |
ICH5204-20mg |
Ifinatamab Biosimilar – Research Grade |
20mg |
2588 |
ICH5204-50mg |
Ifinatamab Biosimilar – Research Grade |
50mg |
2589 |
ICH5204-5mg |
Ifinatamab Biosimilar – Research Grade |
5mg |
2590 |
ICH5205-100mg |
Gresonitamab Biosimilar – Research Grade |
100mg |
2591 |
ICH5205-10mg |
Gresonitamab Biosimilar – Research Grade |
10mg |
2592 |
ICH5205-1mg |
Gresonitamab Biosimilar – Research Grade |
1mg |
2593 |
ICH5205-20mg |
Gresonitamab Biosimilar – Research Grade |
20mg |
2594 |
ICH5205-50mg |
Gresonitamab Biosimilar – Research Grade |
50mg |
2595 |
ICH5205-5mg |
Gresonitamab Biosimilar – Research Grade |
5mg |
2596 |
ICH5206-100mg |
Patritumab Biosimilar – Research Grade |
100mg |
2597 |
ICH5206-10mg |
Patritumab Biosimilar – Research Grade |
10mg |
2598 |
ICH5206-1mg |
Patritumab Biosimilar – Research Grade |
1mg |
2599 |
ICH5206-20mg |
Patritumab Biosimilar – Research Grade |
20mg |
2600 |
ICH5206-50mg |
Patritumab Biosimilar – Research Grade |
50mg |
2601 |
ICH5206-5mg |
Patritumab Biosimilar – Research Grade |
5mg |
2602 |
ICH5207-100mg |
Talquetamab Biosimilar – Research Grade |
100mg |
2603 |
ICH5207-10mg |
Talquetamab Biosimilar – Research Grade |
10mg |
2604 |
ICH5207-1mg |
Talquetamab Biosimilar – Research Grade |
1mg |
2605 |
ICH5207-20mg |
Talquetamab Biosimilar – Research Grade |
20mg |
2606 |
ICH5207-50mg |
Talquetamab Biosimilar – Research Grade |
50mg |
2607 |
ICH5207-5mg |
Talquetamab Biosimilar – Research Grade |
5mg |
2608 |
ICH5208-100mg |
Cadonilimab Biosimilar – Research Grade |
100mg |
2609 |
ICH5208-10mg |
Cadonilimab Biosimilar – Research Grade |
10mg |
2610 |
ICH5208-1mg |
Cadonilimab Biosimilar – Research Grade |
1mg |
2611 |
ICH5208-20mg |
Cadonilimab Biosimilar – Research Grade |
20mg |
2612 |
ICH5208-50mg |
Cadonilimab Biosimilar – Research Grade |
50mg |
2613 |
ICH5208-5mg |
Cadonilimab Biosimilar – Research Grade |
5mg |
2614 |
ICH5209-100mg |
Teclistamab Biosimilar – Research Grade |
100mg |
2615 |
ICH5209-10mg |
Teclistamab Biosimilar – Research Grade |
10mg |
2616 |
ICH5209-1mg |
Teclistamab Biosimilar – Research Grade |
1mg |
2617 |
ICH5209-20mg |
Teclistamab Biosimilar – Research Grade |
20mg |
2618 |
ICH5209-50mg |
Teclistamab Biosimilar – Research Grade |
50mg |
2619 |
ICH5209-5mg |
Teclistamab Biosimilar – Research Grade |
5mg |
2620 |
ICH5210-100mg |
Risankizumab Biosimilar – Research Grade |
100mg |
2621 |
ICH5210-10mg |
Risankizumab Biosimilar – Research Grade |
10mg |
2622 |
ICH5210-1mg |
Risankizumab Biosimilar – Research Grade |
1mg |
2623 |
ICH5210-20mg |
Risankizumab Biosimilar – Research Grade |
20mg |
2624 |
ICH5210-50mg |
Risankizumab Biosimilar – Research Grade |
50mg |
2625 |
ICH5210-5mg |
Risankizumab Biosimilar – Research Grade |
5mg |
2626 |
ICH5211-100mg |
Osemitamab Biosimilar – Research Grade |
100mg |
2627 |
ICH5211-10mg |
Osemitamab Biosimilar – Research Grade |
10mg |
2628 |
ICH5211-1mg |
Osemitamab Biosimilar – Research Grade |
1mg |
2629 |
ICH5211-20mg |
Osemitamab Biosimilar – Research Grade |
20mg |
2630 |
ICH5211-50mg |
Osemitamab Biosimilar – Research Grade |
50mg |
2631 |
ICH5211-5mg |
Osemitamab Biosimilar – Research Grade |
5mg |
2632 |
ICH5212-100mg |
Onartuzumab Biosimilar – Research Grade |
100mg |
2633 |
ICH5212-10mg |
Onartuzumab Biosimilar – Research Grade |
10mg |
2634 |
ICH5212-1mg |
Onartuzumab Biosimilar – Research Grade |
1mg |
2635 |
ICH5212-20mg |
Onartuzumab Biosimilar – Research Grade |
20mg |
2636 |
ICH5212-50mg |
Onartuzumab Biosimilar – Research Grade |
50mg |
2637 |
ICH5212-5mg |
Onartuzumab Biosimilar – Research Grade |
5mg |
2638 |
ICH5213-100mg |
Tezepelumab Biosimilar – Research Grade |
100mg |
2639 |
ICH5213-10mg |
Tezepelumab Biosimilar – Research Grade |
10mg |
2640 |
ICH5213-1mg |
Tezepelumab Biosimilar – Research Grade |
1mg |
2641 |
ICH5213-20mg |
Tezepelumab Biosimilar – Research Grade |
20mg |
2642 |
ICH5213-50mg |
Tezepelumab Biosimilar – Research Grade |
50mg |
2643 |
ICH5213-5mg |
Tezepelumab Biosimilar – Research Grade |
5mg |
2644 |
ICH5214-100mg |
Prezalumab Biosimilar – Research Grade |
100mg |
2645 |
ICH5214-10mg |
Prezalumab Biosimilar – Research Grade |
10mg |
2646 |
ICH5214-1mg |
Prezalumab Biosimilar – Research Grade |
1mg |
2647 |
ICH5214-20mg |
Prezalumab Biosimilar – Research Grade |
20mg |
2648 |
ICH5214-50mg |
Prezalumab Biosimilar – Research Grade |
50mg |
2649 |
ICH5214-5mg |
Prezalumab Biosimilar – Research Grade |
5mg |
2650 |
ICH5215-100mg |
Istiratumab Biosimilar – Research Grade |
100mg |
2651 |
ICH5215-10mg |
Istiratumab Biosimilar – Research Grade |
10mg |
2652 |
ICH5215-1mg |
Istiratumab Biosimilar – Research Grade |
1mg |
2653 |
ICH5215-20mg |
Istiratumab Biosimilar – Research Grade |
20mg |
2654 |
ICH5215-50mg |
Istiratumab Biosimilar – Research Grade |
50mg |
2655 |
ICH5215-5mg |
Istiratumab Biosimilar – Research Grade |
5mg |
2656 |
ICH5216-100mg |
Ganitumab Biosimilar – Research Grade |
100mg |
2657 |
ICH5216-10mg |
Ganitumab Biosimilar – Research Grade |
10mg |
2658 |
ICH5216-1mg |
Ganitumab Biosimilar – Research Grade |
1mg |
2659 |
ICH5216-20mg |
Ganitumab Biosimilar – Research Grade |
20mg |
2660 |
ICH5216-50mg |
Ganitumab Biosimilar – Research Grade |
50mg |
2661 |
ICH5216-5mg |
Ganitumab Biosimilar – Research Grade |
5mg |
2662 |
ICH5217-100mg |
Datopotamab Biosimilar – Research Grade |
100mg |
2663 |
ICH5217-10mg |
Datopotamab Biosimilar – Research Grade |
10mg |
2664 |
ICH5217-1mg |
Datopotamab Biosimilar – Research Grade |
1mg |
2665 |
ICH5217-20mg |
Datopotamab Biosimilar – Research Grade |
20mg |
2666 |
ICH5217-50mg |
Datopotamab Biosimilar – Research Grade |
50mg |
2667 |
ICH5217-5mg |
Datopotamab Biosimilar – Research Grade |
5mg |
2668 |
ICH5218-100mg |
IPH5201 Biosimilar – Research Grade |
100mg |
2669 |
ICH5218-10mg |
IPH5201 Biosimilar – Research Grade |
10mg |
2670 |
ICH5218-1mg |
IPH5201 Biosimilar – Research Grade |
1mg |
2671 |
ICH5218-20mg |
IPH5201 Biosimilar – Research Grade |
20mg |
2672 |
ICH5218-50mg |
IPH5201 Biosimilar – Research Grade |
50mg |
2673 |
ICH5218-5mg |
IPH5201 Biosimilar – Research Grade |
5mg |
2674 |
ICH5219-100mg |
Lecanemab Biosimilar – Research Grade |
100mg |
2675 |
ICH5219-10mg |
Lecanemab Biosimilar – Research Grade |
10mg |
2676 |
ICH5219-1mg |
Lecanemab Biosimilar – Research Grade |
1mg |
2677 |
ICH5219-20mg |
Lecanemab Biosimilar – Research Grade |
20mg |
2678 |
ICH5219-50mg |
Lecanemab Biosimilar – Research Grade |
50mg |
2679 |
ICH5219-5mg |
Lecanemab Biosimilar – Research Grade |
5mg |
2680 |
ICH5220-100mg |
Dazukibart Biosimilar – Research Grade |
100mg |
2681 |
ICH5220-10mg |
Dazukibart Biosimilar – Research Grade |
10mg |
2682 |
ICH5220-1mg |
Dazukibart Biosimilar – Research Grade |
1mg |
2683 |
ICH5220-20mg |
Dazukibart Biosimilar – Research Grade |
20mg |
2684 |
ICH5220-50mg |
Dazukibart Biosimilar – Research Grade |
50mg |
2685 |
ICH5220-5mg |
Dazukibart Biosimilar – Research Grade |
5mg |
2686 |
ICH5221-100mg |
Peresolimab Biosimilar – Research Grade |
100mg |
2687 |
ICH5221-10mg |
Peresolimab Biosimilar – Research Grade |
10mg |
2688 |
ICH5221-1mg |
Peresolimab Biosimilar – Research Grade |
1mg |
2689 |
ICH5221-20mg |
Peresolimab Biosimilar – Research Grade |
20mg |
2690 |
ICH5221-50mg |
Peresolimab Biosimilar – Research Grade |
50mg |
2691 |
ICH5221-5mg |
Peresolimab Biosimilar – Research Grade |
5mg |
2692 |
ICH5222-100mg |
Amivantamab Biosimilar – Research Grade |
100mg |
2693 |
ICH5222-10mg |
Amivantamab Biosimilar – Research Grade |
10mg |
2694 |
ICH5222-1mg |
Amivantamab Biosimilar – Research Grade |
1mg |
2695 |
ICH5222-20mg |
Amivantamab Biosimilar – Research Grade |
20mg |
2696 |
ICH5222-50mg |
Amivantamab Biosimilar – Research Grade |
50mg |
2697 |
ICH5222-5mg |
Amivantamab Biosimilar – Research Grade |
5mg |
2698 |
ICH5223-100mg |
Efgartigimod Biosimilar – Research Grade |
100mg |
2699 |
ICH5223-10mg |
Efgartigimod Biosimilar – Research Grade |
10mg |
2700 |
ICH5223-1mg |
Efgartigimod Biosimilar – Research Grade |
1mg |
2701 |
ICH5223-20mg |
Efgartigimod Biosimilar – Research Grade |
20mg |
2702 |
ICH5223-50mg |
Efgartigimod Biosimilar – Research Grade |
50mg |
2703 |
ICH5223-5mg |
Efgartigimod Biosimilar – Research Grade |
5mg |
2704 |
ICH5224-10mg |
Acrixolimab Biosimilar – Research Grade |
10mg |
2705 |
ICH5224-1mg |
Acrixolimab Biosimilar – Research Grade |
1mg |
2706 |
ICH5224-20mg |
Acrixolimab Biosimilar – Research Grade |
20mg |
2707 |
ICH5224-50mg |
Acrixolimab Biosimilar – Research Grade |
50mg |
2708 |
ICH5224-5mg |
Acrixolimab Biosimilar – Research Grade |
5mg |
2709 |
ICH5225-10mg |
Adebrelimab Biosimilar – Research Grade |
10mg |
2710 |
ICH5225-1mg |
Adebrelimab Biosimilar – Research Grade |
1mg |
2711 |
ICH5225-20mg |
Adebrelimab Biosimilar – Research Grade |
20mg |
2712 |
ICH5225-50mg |
Adebrelimab Biosimilar – Research Grade |
50mg |
2713 |
ICH5225-5mg |
Adebrelimab Biosimilar – Research Grade |
5mg |
2714 |
ICH5226-10mg |
Amlitelimab Biosimilar – Research Grade |
10mg |
2715 |
ICH5226-1mg |
Amlitelimab Biosimilar – Research Grade |
1mg |
2716 |
ICH5226-20mg |
Amlitelimab Biosimilar – Research Grade |
20mg |
2717 |
ICH5226-50mg |
Amlitelimab Biosimilar – Research Grade |
50mg |
2718 |
ICH5226-5mg |
Amlitelimab Biosimilar – Research Grade |
5mg |
2719 |
ICH5227-10mg |
Anumigilimab Biosimilar – Research Grade |
10mg |
2720 |
ICH5227-1mg |
Anumigilimab Biosimilar – Research Grade |
1mg |
2721 |
ICH5227-20mg |
Anumigilimab Biosimilar – Research Grade |
20mg |
2722 |
ICH5227-50mg |
Anumigilimab Biosimilar – Research Grade |
50mg |
2723 |
ICH5227-5mg |
Anumigilimab Biosimilar – Research Grade |
5mg |
2724 |
ICH5228-10mg |
Apitegromab Biosimilar – Research Grade |
10mg |
2725 |
ICH5228-1mg |
Apitegromab Biosimilar – Research Grade |
1mg |
2726 |
ICH5228-20mg |
Apitegromab Biosimilar – Research Grade |
20mg |
2727 |
ICH5228-50mg |
Apitegromab Biosimilar – Research Grade |
50mg |
2728 |
ICH5228-5mg |
Apitegromab Biosimilar – Research Grade |
5mg |
2729 |
ICH5229-10mg |
Aselizumab Biosimilar – Research Grade |
10mg |
2730 |
ICH5229-1mg |
Aselizumab Biosimilar – Research Grade |
1mg |
2731 |
ICH5229-20mg |
Aselizumab Biosimilar – Research Grade |
20mg |
2732 |
ICH5229-50mg |
Aselizumab Biosimilar – Research Grade |
50mg |
2733 |
ICH5229-5mg |
Aselizumab Biosimilar – Research Grade |
5mg |
2734 |
ICH5230-10mg |
Atisnolerbart Biosimilar – Research Grade |
10mg |
2735 |
ICH5230-1mg |
Atisnolerbart Biosimilar – Research Grade |
1mg |
2736 |
ICH5230-20mg |
Atisnolerbart Biosimilar – Research Grade |
20mg |
2737 |
ICH5230-50mg |
Atisnolerbart Biosimilar – Research Grade |
50mg |
2738 |
ICH5230-5mg |
Atisnolerbart Biosimilar – Research Grade |
5mg |
2739 |
ICH5231-10mg |
Bremzalerbart Biosimilar – Research Grade |
10mg |
2740 |
ICH5231-1mg |
Bremzalerbart Biosimilar – Research Grade |
1mg |
2741 |
ICH5231-20mg |
Bremzalerbart Biosimilar – Research Grade |
20mg |
2742 |
ICH5231-50mg |
Bremzalerbart Biosimilar – Research Grade |
50mg |
2743 |
ICH5231-5mg |
Bremzalerbart Biosimilar – Research Grade |
5mg |
2744 |
ICH5232-10mg |
Burfiralimab Biosimilar – Research Grade |
10mg |
2745 |
ICH5232-1mg |
Burfiralimab Biosimilar – Research Grade |
1mg |
2746 |
ICH5232-20mg |
Burfiralimab Biosimilar – Research Grade |
20mg |
2747 |
ICH5232-50mg |
Burfiralimab Biosimilar – Research Grade |
50mg |
2748 |
ICH5232-5mg |
Burfiralimab Biosimilar – Research Grade |
5mg |
2749 |
ICH5233-10mg |
Eblasakimab Biosimilar – Research Grade |
10mg |
2750 |
ICH5233-1mg |
Eblasakimab Biosimilar – Research Grade |
1mg |
2751 |
ICH5233-20mg |
Eblasakimab Biosimilar – Research Grade |
20mg |
2752 |
ICH5233-50mg |
Eblasakimab Biosimilar – Research Grade |
50mg |
2753 |
ICH5233-5mg |
Eblasakimab Biosimilar – Research Grade |
5mg |
2754 |
ICH5234-10mg |
Enlonstobart Biosimilar – Research Grade |
10mg |
2755 |
ICH5234-1mg |
Enlonstobart Biosimilar – Research Grade |
1mg |
2756 |
ICH5234-20mg |
Enlonstobart Biosimilar – Research Grade |
20mg |
2757 |
ICH5234-50mg |
Enlonstobart Biosimilar – Research Grade |
50mg |
2758 |
ICH5234-5mg |
Enlonstobart Biosimilar – Research Grade |
5mg |
2759 |
ICH5235-10mg |
Enuzovimab Biosimilar – Research Grade |
10mg |
2760 |
ICH5235-1mg |
Enuzovimab Biosimilar – Research Grade |
1mg |
2761 |
ICH5235-20mg |
Enuzovimab Biosimilar – Research Grade |
20mg |
2762 |
ICH5235-50mg |
Enuzovimab Biosimilar – Research Grade |
50mg |
2763 |
ICH5235-5mg |
Enuzovimab Biosimilar – Research Grade |
5mg |
2764 |
ICH5236-10mg |
Evunzekibart Biosimilar – Research Grade |
10mg |
2765 |
ICH5236-1mg |
Evunzekibart Biosimilar – Research Grade |
1mg |
2766 |
ICH5236-20mg |
Evunzekibart Biosimilar – Research Grade |
20mg |
2767 |
ICH5236-50mg |
Evunzekibart Biosimilar – Research Grade |
50mg |
2768 |
ICH5236-5mg |
Evunzekibart Biosimilar – Research Grade |
5mg |
2769 |
ICH5237-10mg |
Exidavnemab Biosimilar – Research Grade |
10mg |
2770 |
ICH5237-1mg |
Exidavnemab Biosimilar – Research Grade |
1mg |
2771 |
ICH5237-20mg |
Exidavnemab Biosimilar – Research Grade |
20mg |
2772 |
ICH5237-50mg |
Exidavnemab Biosimilar – Research Grade |
50mg |
2773 |
ICH5237-5mg |
Exidavnemab Biosimilar – Research Grade |
5mg |
2774 |
ICH5238-10mg |
Ezabenlimab Biosimilar – Research Grade |
10mg |
2775 |
ICH5238-1mg |
Ezabenlimab Biosimilar – Research Grade |
1mg |
2776 |
ICH5238-20mg |
Ezabenlimab Biosimilar – Research Grade |
20mg |
2777 |
ICH5238-50mg |
Ezabenlimab Biosimilar – Research Grade |
50mg |
2778 |
ICH5238-5mg |
Ezabenlimab Biosimilar – Research Grade |
5mg |
2779 |
ICH5239-10mg |
Feladilimab Biosimilar – Research Grade |
10mg |
2780 |
ICH5239-1mg |
Feladilimab Biosimilar – Research Grade |
1mg |
2781 |
ICH5239-20mg |
Feladilimab Biosimilar – Research Grade |
20mg |
2782 |
ICH5239-50mg |
Feladilimab Biosimilar – Research Grade |
50mg |
2783 |
ICH5239-5mg |
Feladilimab Biosimilar – Research Grade |
5mg |
2784 |
ICH5240-10mg |
Fepixnebart Biosimilar – Research Grade |
10mg |
2785 |
ICH5240-1mg |
Fepixnebart Biosimilar – Research Grade |
1mg |
2786 |
ICH5240-20mg |
Fepixnebart Biosimilar – Research Grade |
20mg |
2787 |
ICH5240-50mg |
Fepixnebart Biosimilar – Research Grade |
50mg |
2788 |
ICH5240-5mg |
Fepixnebart Biosimilar – Research Grade |
5mg |
2789 |
ICH5241-10mg |
Finotonlimab Biosimilar – Research Grade |
10mg |
2790 |
ICH5241-1mg |
Finotonlimab Biosimilar – Research Grade |
1mg |
2791 |
ICH5241-20mg |
Finotonlimab Biosimilar – Research Grade |
20mg |
2792 |
ICH5241-50mg |
Finotonlimab Biosimilar – Research Grade |
50mg |
2793 |
ICH5241-5mg |
Finotonlimab Biosimilar – Research Grade |
5mg |
2794 |
ICH5242-10mg |
Freneslerbart Biosimilar – Research Grade |
10mg |
2795 |
ICH5242-1mg |
Freneslerbart Biosimilar – Research Grade |
1mg |
2796 |
ICH5242-20mg |
Freneslerbart Biosimilar – Research Grade |
20mg |
2797 |
ICH5242-50mg |
Freneslerbart Biosimilar – Research Grade |
50mg |
2798 |
ICH5242-5mg |
Freneslerbart Biosimilar – Research Grade |
5mg |
2799 |
ICH5243-10mg |
Geptanolimab Biosimilar – Research Grade |
10mg |
2800 |
ICH5243-1mg |
Geptanolimab Biosimilar – Research Grade |
1mg |
2801 |
ICH5243-20mg |
Geptanolimab Biosimilar – Research Grade |
20mg |
2802 |
ICH5243-50mg |
Geptanolimab Biosimilar – Research Grade |
50mg |
2803 |
ICH5243-5mg |
Geptanolimab Biosimilar – Research Grade |
5mg |
2804 |
ICH5244-10mg |
Ginisortamab Biosimilar – Research Grade |
10mg |
2805 |
ICH5244-1mg |
Ginisortamab Biosimilar – Research Grade |
1mg |
2806 |
ICH5244-20mg |
Ginisortamab Biosimilar – Research Grade |
20mg |
2807 |
ICH5244-50mg |
Ginisortamab Biosimilar – Research Grade |
50mg |
2808 |
ICH5244-5mg |
Ginisortamab Biosimilar – Research Grade |
5mg |
2809 |
ICH5245-10mg |
Imsidolimab Biosimilar – Research Grade |
10mg |
2810 |
ICH5245-1mg |
Imsidolimab Biosimilar – Research Grade |
1mg |
2811 |
ICH5245-20mg |
Imsidolimab Biosimilar – Research Grade |
20mg |
2812 |
ICH5245-50mg |
Imsidolimab Biosimilar – Research Grade |
50mg |
2813 |
ICH5245-5mg |
Imsidolimab Biosimilar – Research Grade |
5mg |
2814 |
ICH5246-10mg |
Indatuximab Biosimilar – Research Grade |
10mg |
2815 |
ICH5246-1mg |
Indatuximab Biosimilar – Research Grade |
1mg |
2816 |
ICH5246-20mg |
Indatuximab Biosimilar – Research Grade |
20mg |
2817 |
ICH5246-50mg |
Indatuximab Biosimilar – Research Grade |
50mg |
2818 |
ICH5246-5mg |
Indatuximab Biosimilar – Research Grade |
5mg |
2819 |
ICH5247-10mg |
Inotuzumab Biosimilar – Research Grade |
10mg |
2820 |
ICH5247-1mg |
Inotuzumab Biosimilar – Research Grade |
1mg |
2821 |
ICH5247-20mg |
Inotuzumab Biosimilar – Research Grade |
20mg |
2822 |
ICH5247-50mg |
Inotuzumab Biosimilar – Research Grade |
50mg |
2823 |
ICH5247-5mg |
Inotuzumab Biosimilar – Research Grade |
5mg |
2824 |
ICH5248-10mg |
Iparomlimab Biosimilar – Research Grade |
10mg |
2825 |
ICH5248-1mg |
Iparomlimab Biosimilar – Research Grade |
1mg |
2826 |
ICH5248-20mg |
Iparomlimab Biosimilar – Research Grade |
20mg |
2827 |
ICH5248-50mg |
Iparomlimab Biosimilar – Research Grade |
50mg |
2828 |
ICH5248-5mg |
Iparomlimab Biosimilar – Research Grade |
5mg |
2829 |
ICH5249-10mg |
Itepekimab Biosimilar – Research Grade |
10mg |
2830 |
ICH5249-1mg |
Itepekimab Biosimilar – Research Grade |
1mg |
2831 |
ICH5249-20mg |
Itepekimab Biosimilar – Research Grade |
20mg |
2832 |
ICH5249-50mg |
Itepekimab Biosimilar – Research Grade |
50mg |
2833 |
ICH5249-5mg |
Itepekimab Biosimilar – Research Grade |
5mg |
2834 |
ICH5250-10mg |
Lerdelimumab Biosimilar – Research Grade |
10mg |
2835 |
ICH5250-1mg |
Lerdelimumab Biosimilar – Research Grade |
1mg |
2836 |
ICH5250-20mg |
Lerdelimumab Biosimilar – Research Grade |
20mg |
2837 |
ICH5250-50mg |
Lerdelimumab Biosimilar – Research Grade |
50mg |
2838 |
ICH5250-5mg |
Lerdelimumab Biosimilar – Research Grade |
5mg |
2839 |
ICH5251-10mg |
Letaplimab Biosimilar – Research Grade |
10mg |
2840 |
ICH5251-1mg |
Letaplimab Biosimilar – Research Grade |
1mg |
2841 |
ICH5251-20mg |
Letaplimab Biosimilar – Research Grade |
20mg |
2842 |
ICH5251-50mg |
Letaplimab Biosimilar – Research Grade |
50mg |
2843 |
ICH5251-5mg |
Letaplimab Biosimilar – Research Grade |
5mg |
2844 |
ICH5252-10mg |
Ligufalimab Biosimilar – Research Grade |
10mg |
2845 |
ICH5252-1mg |
Ligufalimab Biosimilar – Research Grade |
1mg |
2846 |
ICH5252-20mg |
Ligufalimab Biosimilar – Research Grade |
20mg |
2847 |
ICH5252-50mg |
Ligufalimab Biosimilar – Research Grade |
50mg |
2848 |
ICH5252-5mg |
Ligufalimab Biosimilar – Research Grade |
5mg |
2849 |
ICH5253-10mg |
Linavonkibart Biosimilar – Research Grade |
10mg |
2850 |
ICH5253-1mg |
Linavonkibart Biosimilar – Research Grade |
1mg |
2851 |
ICH5253-20mg |
Linavonkibart Biosimilar – Research Grade |
20mg |
2852 |
ICH5253-50mg |
Linavonkibart Biosimilar – Research Grade |
50mg |
2853 |
ICH5253-5mg |
Linavonkibart Biosimilar – Research Grade |
5mg |
2854 |
ICH5254-10mg |
Lipustobart Biosimilar – Research Grade |
10mg |
2855 |
ICH5254-1mg |
Lipustobart Biosimilar – Research Grade |
1mg |
2856 |
ICH5254-20mg |
Lipustobart Biosimilar – Research Grade |
20mg |
2857 |
ICH5254-50mg |
Lipustobart Biosimilar – Research Grade |
50mg |
2858 |
ICH5254-5mg |
Lipustobart Biosimilar – Research Grade |
5mg |
2859 |
ICH5255-10mg |
Livmoniplimab Biosimilar – Research Grade |
10mg |
2860 |
ICH5255-1mg |
Livmoniplimab Biosimilar – Research Grade |
1mg |
2861 |
ICH5255-20mg |
Livmoniplimab Biosimilar – Research Grade |
20mg |
2862 |
ICH5255-50mg |
Livmoniplimab Biosimilar – Research Grade |
50mg |
2863 |
ICH5255-5mg |
Livmoniplimab Biosimilar – Research Grade |
5mg |
2864 |
ICH5256-10mg |
Manfidokimab Biosimilar – Research Grade |
10mg |
2865 |
ICH5256-1mg |
Manfidokimab Biosimilar – Research Grade |
1mg |
2866 |
ICH5256-20mg |
Manfidokimab Biosimilar – Research Grade |
20mg |
2867 |
ICH5256-50mg |
Manfidokimab Biosimilar – Research Grade |
50mg |
2868 |
ICH5256-5mg |
Manfidokimab Biosimilar – Research Grade |
5mg |
2869 |
ICH5257-10mg |
Metelimumab Biosimilar – Research Grade |
10mg |
2870 |
ICH5257-1mg |
Metelimumab Biosimilar – Research Grade |
1mg |
2871 |
ICH5257-20mg |
Metelimumab Biosimilar – Research Grade |
20mg |
2872 |
ICH5257-50mg |
Metelimumab Biosimilar – Research Grade |
50mg |
2873 |
ICH5257-5mg |
Metelimumab Biosimilar – Research Grade |
5mg |
2874 |
ICH5258-10mg |
Mibavademab Biosimilar – Research Grade |
10mg |
2875 |
ICH5258-1mg |
Mibavademab Biosimilar – Research Grade |
1mg |
2876 |
ICH5258-20mg |
Mibavademab Biosimilar – Research Grade |
20mg |
2877 |
ICH5258-50mg |
Mibavademab Biosimilar – Research Grade |
50mg |
2878 |
ICH5258-5mg |
Mibavademab Biosimilar – Research Grade |
5mg |
2879 |
ICH5259-10mg |
Miptenalimab Biosimilar – Research Grade |
10mg |
2880 |
ICH5259-1mg |
Miptenalimab Biosimilar – Research Grade |
1mg |
2881 |
ICH5259-20mg |
Miptenalimab Biosimilar – Research Grade |
20mg |
2882 |
ICH5259-50mg |
Miptenalimab Biosimilar – Research Grade |
50mg |
2883 |
ICH5259-5mg |
Miptenalimab Biosimilar – Research Grade |
5mg |
2884 |
ICH5260-10mg |
Nadecnemab Biosimilar – Research Grade |
10mg |
2885 |
ICH5260-1mg |
Nadecnemab Biosimilar – Research Grade |
1mg |
2886 |
ICH5260-20mg |
Nadecnemab Biosimilar – Research Grade |
20mg |
2887 |
ICH5260-50mg |
Nadecnemab Biosimilar – Research Grade |
50mg |
2888 |
ICH5260-5mg |
Nadecnemab Biosimilar – Research Grade |
5mg |
2889 |
ICH5261-10mg |
Narlumosbart Biosimilar – Research Grade |
10mg |
2890 |
ICH5261-1mg |
Narlumosbart Biosimilar – Research Grade |
1mg |
2891 |
ICH5261-20mg |
Narlumosbart Biosimilar – Research Grade |
20mg |
2892 |
ICH5261-50mg |
Narlumosbart Biosimilar – Research Grade |
50mg |
2893 |
ICH5261-5mg |
Narlumosbart Biosimilar – Research Grade |
5mg |
2894 |
ICH5262-10mg |
Nofazinlimab Biosimilar – Research Grade |
10mg |
2895 |
ICH5262-1mg |
Nofazinlimab Biosimilar – Research Grade |
1mg |
2896 |
ICH5262-20mg |
Nofazinlimab Biosimilar – Research Grade |
20mg |
2897 |
ICH5262-50mg |
Nofazinlimab Biosimilar – Research Grade |
50mg |
2898 |
ICH5262-5mg |
Nofazinlimab Biosimilar – Research Grade |
5mg |
2899 |
ICH5263-10mg |
Oloctinebart Biosimilar – Research Grade |
10mg |
2900 |
ICH5263-1mg |
Oloctinebart Biosimilar – Research Grade |
1mg |
2901 |
ICH5263-20mg |
Oloctinebart Biosimilar – Research Grade |
20mg |
2902 |
ICH5263-50mg |
Oloctinebart Biosimilar – Research Grade |
50mg |
2903 |
ICH5263-5mg |
Oloctinebart Biosimilar – Research Grade |
5mg |
2904 |
ICH5264-10mg |
Patecibart Biosimilar – Research Grade |
10mg |
2905 |
ICH5264-1mg |
Patecibart Biosimilar – Research Grade |
1mg |
2906 |
ICH5264-20mg |
Patecibart Biosimilar – Research Grade |
20mg |
2907 |
ICH5264-50mg |
Patecibart Biosimilar – Research Grade |
50mg |
2908 |
ICH5264-5mg |
Patecibart Biosimilar – Research Grade |
5mg |
2909 |
ICH5265-10mg |
Perenostobart Biosimilar – Research Grade |
10mg |
2910 |
ICH5265-1mg |
Perenostobart Biosimilar – Research Grade |
1mg |
2911 |
ICH5265-20mg |
Perenostobart Biosimilar – Research Grade |
20mg |
2912 |
ICH5265-50mg |
Perenostobart Biosimilar – Research Grade |
50mg |
2913 |
ICH5265-5mg |
Perenostobart Biosimilar – Research Grade |
5mg |
2914 |
ICH5266-10mg |
Pimivalimab Biosimilar – Research Grade |
10mg |
2915 |
ICH5266-1mg |
Pimivalimab Biosimilar – Research Grade |
1mg |
2916 |
ICH5266-20mg |
Pimivalimab Biosimilar – Research Grade |
20mg |
2917 |
ICH5266-50mg |
Pimivalimab Biosimilar – Research Grade |
50mg |
2918 |
ICH5266-5mg |
Pimivalimab Biosimilar – Research Grade |
5mg |
2919 |
ICH5267-10mg |
Polzastobart Biosimilar – Research Grade |
10mg |
2920 |
ICH5267-1mg |
Polzastobart Biosimilar – Research Grade |
1mg |
2921 |
ICH5267-20mg |
Polzastobart Biosimilar – Research Grade |
20mg |
2922 |
ICH5267-50mg |
Polzastobart Biosimilar – Research Grade |
50mg |
2923 |
ICH5267-5mg |
Polzastobart Biosimilar – Research Grade |
5mg |
2924 |
ICH5268-10mg |
Pradusinstobart Biosimilar – Research Grade |
10mg |
2925 |
ICH5268-1mg |
Pradusinstobart Biosimilar – Research Grade |
1mg |
2926 |
ICH5268-20mg |
Pradusinstobart Biosimilar – Research Grade |
20mg |
2927 |
ICH5268-50mg |
Pradusinstobart Biosimilar – Research Grade |
50mg |
2928 |
ICH5268-5mg |
Pradusinstobart Biosimilar – Research Grade |
5mg |
2929 |
ICH5269-10mg |
Pucotenlimab Biosimilar – Research Grade |
10mg |
2930 |
ICH5269-1mg |
Pucotenlimab Biosimilar – Research Grade |
1mg |
2931 |
ICH5269-20mg |
Pucotenlimab Biosimilar – Research Grade |
20mg |
2932 |
ICH5269-50mg |
Pucotenlimab Biosimilar – Research Grade |
50mg |
2933 |
ICH5269-5mg |
Pucotenlimab Biosimilar – Research Grade |
5mg |
2934 |
ICH5270-10mg |
Quisovalimab Biosimilar – Research Grade |
10mg |
2935 |
ICH5270-1mg |
Quisovalimab Biosimilar – Research Grade |
1mg |
2936 |
ICH5270-20mg |
Quisovalimab Biosimilar – Research Grade |
20mg |
2937 |
ICH5270-50mg |
Quisovalimab Biosimilar – Research Grade |
50mg |
2938 |
ICH5270-5mg |
Quisovalimab Biosimilar – Research Grade |
5mg |
2939 |
ICH5271-10mg |
Rademikibart Biosimilar – Research Grade |
10mg |
2940 |
ICH5271-1mg |
Rademikibart Biosimilar – Research Grade |
1mg |
2941 |
ICH5271-20mg |
Rademikibart Biosimilar – Research Grade |
20mg |
2942 |
ICH5271-50mg |
Rademikibart Biosimilar – Research Grade |
50mg |
2943 |
ICH5271-5mg |
Rademikibart Biosimilar – Research Grade |
5mg |
2944 |
ICH5272-10mg |
Reslizumab Biosimilar – Research Grade |
10mg |
2945 |
ICH5272-1mg |
Reslizumab Biosimilar – Research Grade |
1mg |
2946 |
ICH5272-20mg |
Reslizumab Biosimilar – Research Grade |
20mg |
2947 |
ICH5272-50mg |
Reslizumab Biosimilar – Research Grade |
50mg |
2948 |
ICH5272-5mg |
Reslizumab Biosimilar – Research Grade |
5mg |
2949 |
ICH5273-10mg |
Riliprubart Biosimilar – Research Grade |
10mg |
2950 |
ICH5273-1mg |
Riliprubart Biosimilar – Research Grade |
1mg |
2951 |
ICH5273-20mg |
Riliprubart Biosimilar – Research Grade |
20mg |
2952 |
ICH5273-50mg |
Riliprubart Biosimilar – Research Grade |
50mg |
2953 |
ICH5273-5mg |
Riliprubart Biosimilar – Research Grade |
5mg |
2954 |
ICH5274-10mg |
Rolistobart Biosimilar – Research Grade |
10mg |
2955 |
ICH5274-1mg |
Rolistobart Biosimilar – Research Grade |
1mg |
2956 |
ICH5274-20mg |
Rolistobart Biosimilar – Research Grade |
20mg |
2957 |
ICH5274-50mg |
Rolistobart Biosimilar – Research Grade |
50mg |
2958 |
ICH5274-5mg |
Rolistobart Biosimilar – Research Grade |
5mg |
2959 |
ICH5275-10mg |
Rovelizumab Biosimilar – Research Grade |
10mg |
2960 |
ICH5275-1mg |
Rovelizumab Biosimilar – Research Grade |
1mg |
2961 |
ICH5275-20mg |
Rovelizumab Biosimilar – Research Grade |
20mg |
2962 |
ICH5275-50mg |
Rovelizumab Biosimilar – Research Grade |
50mg |
2963 |
ICH5275-5mg |
Rovelizumab Biosimilar – Research Grade |
5mg |
2964 |
ICH5276-10mg |
Sirexatamab Biosimilar – Research Grade |
10mg |
2965 |
ICH5276-1mg |
Sirexatamab Biosimilar – Research Grade |
1mg |
2966 |
ICH5276-20mg |
Sirexatamab Biosimilar – Research Grade |
20mg |
2967 |
ICH5276-50mg |
Sirexatamab Biosimilar – Research Grade |
50mg |
2968 |
ICH5276-5mg |
Sirexatamab Biosimilar – Research Grade |
5mg |
2969 |
ICH5277-10mg |
Stapokibart Biosimilar – Research Grade |
10mg |
2970 |
ICH5277-1mg |
Stapokibart Biosimilar – Research Grade |
1mg |
2971 |
ICH5277-20mg |
Stapokibart Biosimilar – Research Grade |
20mg |
2972 |
ICH5277-50mg |
Stapokibart Biosimilar – Research Grade |
50mg |
2973 |
ICH5277-5mg |
Stapokibart Biosimilar – Research Grade |
5mg |
2974 |
ICH5278-10mg |
Sugemalimab Biosimilar – Research Grade |
10mg |
2975 |
ICH5278-1mg |
Sugemalimab Biosimilar – Research Grade |
1mg |
2976 |
ICH5278-20mg |
Sugemalimab Biosimilar – Research Grade |
20mg |
2977 |
ICH5278-50mg |
Sugemalimab Biosimilar – Research Grade |
50mg |
2978 |
ICH5278-5mg |
Sugemalimab Biosimilar – Research Grade |
5mg |
2979 |
ICH5279-10mg |
Tamgiblimab Biosimilar – Research Grade |
10mg |
2980 |
ICH5279-1mg |
Tamgiblimab Biosimilar – Research Grade |
1mg |
2981 |
ICH5279-20mg |
Tamgiblimab Biosimilar – Research Grade |
20mg |
2982 |
ICH5279-50mg |
Tamgiblimab Biosimilar – Research Grade |
50mg |
2983 |
ICH5279-5mg |
Tamgiblimab Biosimilar – Research Grade |
5mg |
2984 |
ICH5280-10mg |
Torudokimab Biosimilar – Research Grade |
10mg |
2985 |
ICH5280-1mg |
Torudokimab Biosimilar – Research Grade |
1mg |
2986 |
ICH5280-20mg |
Torudokimab Biosimilar – Research Grade |
20mg |
2987 |
ICH5280-50mg |
Torudokimab Biosimilar – Research Grade |
50mg |
2988 |
ICH5280-5mg |
Torudokimab Biosimilar – Research Grade |
5mg |
2989 |
ICH5281-10mg |
Trabikibart Biosimilar – Research Grade |
10mg |
2990 |
ICH5281-1mg |
Trabikibart Biosimilar – Research Grade |
1mg |
2991 |
ICH5281-20mg |
Trabikibart Biosimilar – Research Grade |
20mg |
2992 |
ICH5281-50mg |
Trabikibart Biosimilar – Research Grade |
50mg |
2993 |
ICH5281-5mg |
Trabikibart Biosimilar – Research Grade |
5mg |
2994 |
ICH5282-10mg |
Umesolerbart Biosimilar – Research Grade |
10mg |
2995 |
ICH5282-1mg |
Umesolerbart Biosimilar – Research Grade |
1mg |
2996 |
ICH5282-20mg |
Umesolerbart Biosimilar – Research Grade |
20mg |
2997 |
ICH5282-50mg |
Umesolerbart Biosimilar – Research Grade |
50mg |
2998 |
ICH5282-5mg |
Umesolerbart Biosimilar – Research Grade |
5mg |
2999 |
ICH5283-10mg |
Varokibart Biosimilar – Research Grade |
10mg |
3000 |
ICH5283-1mg |
Varokibart Biosimilar – Research Grade |
1mg |